Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease (Q44991382)

8 December 2017

title

Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

8 December 2017

main subject

0 references

1 reference

1 reference

1 reference

8 December 2017

Shalender Bhasin

1 reference

8 December 2017

Richard Casaburi

1 reference

8 December 2017

Louis Cosentino

1 reference

8 December 2017

Attila Somfay

1 reference

8 December 2017

Michael I Lewis

1 reference

8 December 2017

Mario Fournier

1 reference

8 December 2017

Thomas W Storer

1 reference

8 December 2017

language of work or name

English

0 references

publication date

21 July 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

8 December 2017

published in

1 reference

8 December 2017

volume

170

1 reference

8 December 2017

1 reference

8 December 2017

page(s)

870-878

1 reference

Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Reversal of COPD-associated weight loss using the anabolic agent oxandrolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

ATS/ERS Statement on respiratory muscle testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Body composition and exercise performance in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Tumor necrosis factor-alpha and muscle wasting: a cellular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Secondary hypogonadism in older men: its relation to impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Hypothalamic-pituitary dysfunction in respiratory hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Atrophy of Leydig cells in the testes of men with longstanding chronic bronchitis and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Reduction of serum testosterone levels during chronic glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Testosterone replacement therapy in older adult men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Testosterone administration to older men improves muscle function: molecular and physiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Effect of testosterone treatment on bone mineral density in men over 65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Aerobic and strength training in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-617OC

10.1164/RCCM.200305-617OC

21 January 2018

Identifiers

DOI

1 reference

release_llxydnhd5jg2tnuy7lpdov4m6y

8 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/llxydnhd5jg2tnuy7lpdov4m6y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference